Associated Papers
PTPRA Phosphatase Regulates GDNF-Dependent RET Signaling and Inhibits the RET Mutant MEN2A Oncogenic Potential.
Yadav L et al.
Iscience, 2020
Functional characterization of a novel FGFR1OP-RET rearrangement in hematopoietic malignancies.
Bossi D et al.
Molecular Oncology, 2014
RET is a potential tumor suppressor gene in colorectal cancer.
Luo Y et al.
Oncogene, 2013
RET modulates cell adhesion via its cleavage by caspase in sympathetic neurons.
Cabrera JR et al.
The Journal of Biological Chemistry, 2011
The RET51/FKBP52 complex and its involvement in Parkinson disease.
Fusco D et al.
Human Molecular Genetics, 2010
The tyrosine kinase receptor RET interacts in vivo with aryl hydrocarbon receptor-interacting protein to alter survivin availability.
Vargiolu M et al.
The Journal of Clinical Endocrinology and Metabolism, 2009
A novel activating mutation in the RET tyrosine kinase domain mediates neoplastic transformation.
Cranston A et al.
Molecular Endocrinology (baltimore, Md.), 2006
Biological effects of the dual phenotypic Janus mutation of ret cosegregating with both multiple endocrine neoplasia type 2 and Hirschsprung's disease.
Arighi E et al.
Molecular Endocrinology (baltimore, Md.), 2004
Select a paper to view details